Use of natural compounds in the management of diabetic peripheral neuropathy.
about
Amplitude of sensory nerve action potential in early stage diabetic peripheral neuropathy: an analysis of 500 cases.Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation.Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms.Cannabinoids: new promising agents in the treatment of neurological diseases.The Effect of Medical Marijuana Laws on Body Weight.Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.Luteolin improves the impaired nerve functions in diabetic neuropathy: behavioral and biochemical evidences.
P2860
Q34163258-76AD9C42-31BD-43E5-B65C-8BCD4ACFC60AQ35837088-784DEE95-C73E-4837-8D4E-F4248E9834BDQ35935050-AED544FC-4354-48DB-B429-70CC5AF5A412Q38269376-C2F4E9A9-B99D-465E-8F57-C91510A2C18BQ40280337-21D12FDB-A822-4ECD-BD5C-A23E79319875Q41578115-27CF1CB0-ECC8-4479-8159-3CF567005803Q43183929-3714F2B0-08C7-4FCB-8A29-501E3A07FCF5
P2860
Use of natural compounds in the management of diabetic peripheral neuropathy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Use of natural compounds in the management of diabetic peripheral neuropathy.
@en
type
label
Use of natural compounds in the management of diabetic peripheral neuropathy.
@en
prefLabel
Use of natural compounds in the management of diabetic peripheral neuropathy.
@en
P2093
P2860
P1433
P1476
Use of natural compounds in the management of diabetic peripheral neuropathy
@en
P2093
Emanuela Mazzon
Maria Galuppo
Placido Bramanti
P2860
P304
P356
10.3390/MOLECULES19032877
P407
P577
2014-03-05T00:00:00Z